Thrombotic microangiopathy associated with intravenous injection of extended-release oxycodone

Kate J Robson1, Danielle Clucas2, Robin Filshie3

  • 1Department of Nephrology, Western Health, Melbourne, Australia.

BMJ Case Reports
|July 19, 2017
PubMed

Insights

Intravenous misuse of extended-release oxycodone hydrochloride (Oxycontin) can cause thrombotic microangiopathy (TMA). This case highlights diagnostic challenges and the potential role of eculizumab in managing drug-associated TMA.

Area of Science:

  • Nephrology
  • Toxicology
  • Hematology

Background:

  • Thrombotic microangiopathy (TMA) is a serious condition.
  • Intravenous misuse of extended-release medications poses unique risks.
  • Tamper-resistant formulations may lead to novel routes of abuse.

Observation:

  • A 35-year-old man developed TMA and renal impairment after injecting oral Oxycontin.
  • The patient experienced relapsing TMA despite treatment with eculizumab.
  • Previous cases of TMA linked to intravenous misuse of extended-release oxymorphone (Opana ER) and Oxycontin have been reported.

Findings:

  • This is the first documented case of TMA associated with intravenous Oxycontin misuse where eculizumab was administered.
  • Recurrent TMA was observed despite eculizumab treatment, suggesting limited efficacy in this context.
  • Diagnostic challenges in identifying TMA disorders are highlighted.

Implications:

  • Emphasizes the critical importance of obtaining a thorough drug history in patients presenting with TMA.
  • Raises questions about the efficacy of eculizumab in managing drug-induced TMA.
  • Underscores the need for further research into the mechanisms and management of TMA associated with prescription opioid misuse.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
343
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
47
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
312
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
64
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K